Apollo Therapeutics

Apollo Therapeutics is a biopharmaceutical company rapidly advancing a robust pipeline of potentially transformative therapeutic programs based on breakthrough discoveries. Through deep relationships with world-leading universities and scientists, the company identifies programs with strong biological hypotheses and potential to become meaningful new treatment options. Apollos portfolio-based model combines a centralized team of drug development architects and subject matter experts who are able to rigorously evaluate therapeutic programs in an objective, data-driven manner prioritizing critical experiments to de-risk programs early. This capital efficiency allows Apollo to focus on scaling a robust and potentially transformative pipeline, with over 15 therapeutic programs in...

Biotechnology,biopharmaceuticals,therapeutics,oncology,major inflammatory disorders,and rare disease

Apollo therapeutics operates in the Biotechnology research industry.

Apollo therapeutics's revenue is 11m - 100m

Apollo therapeutics has 51 - 200 employees.